Quarterly Consolidated Statement Of Cash Flows

COSMOS Pharmaceutical Corporation - Filing #7590008

Concept 2021-06-01 to
2022-05-31
As at
2022-05-31
2020-06-01 to
2021-05-31
As at
2021-05-31
As at
2020-05-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
45,382,000,000 JPY
36,968,000,000 JPY
Interest and dividends received
0 JPY
0 JPY
Interest paid
-52,000,000 JPY
-60,000,000 JPY
Income taxes paid
-13,337,000,000 JPY
-9,103,000,000 JPY
Net cash provided by (used in) operating activities
32,194,000,000 JPY
27,875,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-43,497,000,000 JPY
-26,064,000,000 JPY
Proceeds from sale of property, plant and equipment
1,519,000,000 JPY
8,677,000,000 JPY
Other, net
-915,000,000 JPY
-1,671,000,000 JPY
Net cash provided by (used in) investing activities
-43,717,000,000 JPY
-19,381,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
300,000,000 JPY
JPY
Repayments of long-term borrowings
-1,486,000,000 JPY
-1,486,000,000 JPY
Purchase of treasury shares
-2,000,000 JPY
0 JPY
Dividends paid
-3,266,000,000 JPY
-2,277,000,000 JPY
Net cash provided by (used in) financing activities
-6,222,000,000 JPY
-5,507,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
JPY
JPY
Net increase (decrease) in cash and cash equivalents
-17,745,000,000 JPY
2,985,000,000 JPY
Cash and cash equivalents
37,362,000,000 JPY
55,108,000,000 JPY
52,122,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.